Euro USA Inc’s seafood HACCP plans had inadequate temperature limits, monitoring, and corrective actions.
What happened
FDA inspected Euro USA Inc’s seafood processing facility from July 10 to July 25, 2023, and issued a Form FDA 483. FDA found serious violations in seafood HACCP (Hazard Analysis and Critical Control Point) plans for combined molluscan shellfish, pasteurized crabmeat, and scombroid fish, including inadequate critical limits, monitoring, corrective actions, and sanitation monitoring. Records showed seafood storage cooler temperatures exceeded limits and ice adequacy was not checked on multiple dates.
What FDA found
The HACCP plans for combined molluscan shellfish, pasteurized crabmeat, and scombroid fish listed critical limits that were not adequate to control Clostridium botulinum, pathogen growth and toxin formation, and histamine formation.
21 CFR 123.6(c)(3)The firm did not follow the monitoring and verification procedures in its HACCP plans, including checking ice adequacy and taking fish internal temperatures.
21 CFR 123.6(b), (c)(4)The firm did not take appropriate corrective actions when storage cooler temperatures exceeded critical limits.
21 CFR 123.7(a)The HACCP plans’ corrective action plans did not ensure affected product was kept out of commerce and the cause was corrected.
21 CFR 123.7(b); 21 CFR 123.6(c)(5)The firm did not monitor key sanitation areas with sufficient frequency.
21 CFR 123.11(b)
What FDA wants
FDA tells the company to notify it in writing within 15 working days of the specific steps taken to address the violations, including explanations and documentation. If corrective actions cannot be completed in that time, the company must state the reason and the time within which it will complete them.
Who should pay attention
- seafood processors with similar HACCP plans
- retailers and brands buying refrigerated seafood
- quality teams managing cooler monitoring and sanitation records
This is a summary. Read the original letter on fda.gov.